Paul Campanelli
Chief Executive Officer bei PAR PHARMACEUTICAL COMPANIES, INC.
Profil
Paul V.
Campanelli is currently the Chief Executive Officer & Director at Endo Generics Holdings, Inc. and the Chief Executive Officer at Endo Health Solutions, Inc. He is also a Director at Pharmaceutical Associates, Inc., Slayback Pharma LLC, and Convey Health Solutions Holdings, Inc. Additionally, he serves as an Independent Director at Convey Health Solutions Holdings, Inc. and as a Strategic Operating Partner at Bourne Capital Partners LLC (Private Equity).
Previously, Mr. Campanelli held the position of Chief Executive Officer at Endo Pharmaceuticals Solutions, Inc. and Chairman at Endo International Plc.
He was also the President, Chief Operating Officer & Director at Par Pharmaceutical, Inc. and a Director at Par Pharmaceutical Holdings, Inc. Furthermore, he worked as the Vice President-Business Development at Dr. Reddy's Laboratories, Inc. Mr. Campanelli completed his undergraduate degree at Springfield College.
Aktive Positionen von Paul Campanelli
Unternehmen | Position | Beginn |
---|---|---|
PAR PHARMACEUTICAL COMPANIES, INC. | Chief Executive Officer | 01.09.2012 |
CONVEY HEALTH SOLUTIONS HOLDINGS, INC. | Director/Board Member | 14.02.2022 |
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Chief Executive Officer | 01.09.2016 |
Slayback Pharma LLC
Slayback Pharma LLC Pharmaceuticals: GenericHealth Technology Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ. | Director/Board Member | 26.02.2021 |
Pharmaceutical Associates, Inc.
Pharmaceutical Associates, Inc. Pharmaceuticals: MajorHealth Technology Part of Beach Products, Inc., Pharmaceutical Associates, Inc. is a leading manufacturer and marketer of generic liquid pharmaceuticals. The private company is based in Greenville, SC. The company has been producing better-targeted suspensions, oral solutions, elixirs, syrups, and liquids for almost 50 years. The company offers standard bottle packaging and ready-to-dispense packaging to meet the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies. Pharmaceutical Associates was the first independent manufacturer to develop vertically integrated unit-dose (ud) packaging and the first to offer complete lines of hard-to-find liquid products in both out-patient and ud packaging. The CEO of the company is Kurt J. Orlofski. | Director/Board Member | - |
Bourne Capital Partners LLC (Private Equity)
Bourne Capital Partners LLC (Private Equity) Investment ManagersFinance Bourne Capital Partners LLC (Bourne Partners) is a private equity firm founded in 2001 by Banks Bourne. The firm is headquartered in Charlotte, North Carolina. | Consultant / Advisor | 01.05.2021 |
Ehemalige bekannte Positionen von Paul Campanelli
Unternehmen | Position | Ende |
---|---|---|
ENDO INTERNATIONAL PLC | Chief Executive Officer | 06.03.2020 |
Par Pharmaceutical Holdings, Inc.
Par Pharmaceutical Holdings, Inc. MiscellaneousMiscellaneous Par Pharmaceutical Holdings, Inc. operates as a holding company that engages in the development, license, manufacture, market, and distribution of generic drugs. The company was founded on July 12, 2012 and is headquartered in New York. | Director/Board Member | 01.01.2015 |
Dr. Reddy's Laboratories, Inc.
Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Dr. Reddy's Laboratories, Inc. develops pharmaceutical products. It also provides research and development activities and other medical testing services. The company is headquartered in Charlotte, NC. | Corporate Officer/Principal | 01.01.2001 |
░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Ausbildung von Paul Campanelli
Springfield College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 11 |
---|---|
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
Dr. Reddy's Laboratories, Inc.
Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Dr. Reddy's Laboratories, Inc. develops pharmaceutical products. It also provides research and development activities and other medical testing services. The company is headquartered in Charlotte, NC. | Health Services |
Endo Pharmaceuticals Solutions, Inc.
Endo Pharmaceuticals Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals Solutions, Inc. develops products to treat conditions in urology and endocrinology. The company was founded in 2009 and is headquartered in Malvern, PA. | Health Technology |
Pharmaceutical Associates, Inc.
Pharmaceutical Associates, Inc. Pharmaceuticals: MajorHealth Technology Part of Beach Products, Inc., Pharmaceutical Associates, Inc. is a leading manufacturer and marketer of generic liquid pharmaceuticals. The private company is based in Greenville, SC. The company has been producing better-targeted suspensions, oral solutions, elixirs, syrups, and liquids for almost 50 years. The company offers standard bottle packaging and ready-to-dispense packaging to meet the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies. Pharmaceutical Associates was the first independent manufacturer to develop vertically integrated unit-dose (ud) packaging and the first to offer complete lines of hard-to-find liquid products in both out-patient and ud packaging. The CEO of the company is Kurt J. Orlofski. | Health Technology |
Par Pharmaceutical Holdings, Inc.
Par Pharmaceutical Holdings, Inc. MiscellaneousMiscellaneous Par Pharmaceutical Holdings, Inc. operates as a holding company that engages in the development, license, manufacture, market, and distribution of generic drugs. The company was founded on July 12, 2012 and is headquartered in New York. | Miscellaneous |
Bourne Capital Partners LLC (Private Equity)
Bourne Capital Partners LLC (Private Equity) Investment ManagersFinance Bourne Capital Partners LLC (Bourne Partners) is a private equity firm founded in 2001 by Banks Bourne. The firm is headquartered in Charlotte, North Carolina. | Finance |
Slayback Pharma LLC
Slayback Pharma LLC Pharmaceuticals: GenericHealth Technology Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ. | Health Technology |
Convey Health Solutions Holdings, Inc.
Convey Health Solutions Holdings, Inc. Packaged SoftwareTechnology Services Convey Health Solutions Holdings, Inc. engages in the provision of technology enabled solutions. Its platform combines proprietary modular technology and end-to-end solutions to serve as an extension of the clients' operations and core systems. The company was founded on June 13, 2019 and is headquartered in Fort Lauderdale, FL. | Technology Services |